Repurposing drugs to address the crisis of antimicrobial resistance
22 July 2025 - EVENT
Speakers:
– Freda Jen, Research Leader, Institute for Biomedicine and Glycomics, Griffith University (Australia)
– Anthony Coates, Founder, Director & Chief Scientific Officer Helperby Therapeutics Group Ltd and Professor of Medical Microbiology, City St Georges, University of London (UK)
– François Franceschi, Associate Director – SBI Portfolio, GARDP (Switzerland)
Presentation 1: Repurposing a drug candidate originally developed for Alzheimer’s and Huntington’s diseases to treat resistant Neisseria gonorrhoeae infections (Freda Jen) Presentation 2: An antiviral used in the management and treatment of HIV that is being repurposed as an antibacterial (Anthony Coates) Presentation 3: A veterinary drug that is being examined at GARDP to treat drug-resistant infections in humans (François Franceschi)
This live webinar including an interactive Q&A session.
Date and time:
22 July 2025 at 09:30-11:00 CEST
Dedicated registration link here
